'Huge pipeline': Why this beaten-up ASX 200 share could have major growth potential

A fund manager has picked out a beaten-up opportunity for investors.

| More on:
a farmer kneels on one leg and closely examines soil from his farm against a blue sky backdrop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One fund manager has singled out the S&P/ASX 200 Index (ASX: XJO) share Nufarm Ltd (ASX: NUF) as an investing opportunity.

L1 Capital has given a vote of confidence in the ASX agriculture share, particularly at its current share price.

For investors who aren't familiar with the company, Nufarm describes itself as a global crop protection and seed technology specialist. Nufarm was reportedly the first operation to develop and commercialise planted-based Omega-3 and has also developed and commercialised advanced bioenergy feedstock technology.

As we can see on the chart below, the Nufarm share price is down by around 30% since its 52-week high in December 2022.

Why does L1 like the ASX 200 share?

The fund manager explained Nufarm's recent trading was impacted by weaker US rainfall and "transitory farmer de-stocking impacts".

L1 said the "world's leading Omega-3 seed technology" has the potential to deliver a "step change" in Nufarm's earnings in FY25 or FY26. It pointed out the long-term growth aspiration of the company is to grow earnings before interest, tax, depreciation and amortisation (EBITDA) from $59 million in FY22 to $146 million in FY26.

The L1 investment team says there is a huge pipeline of crop protection product launches.

It also likes the valuation the Nufarm share price is trading at, which I'll get to in a moment.

FY23 outlook

Just over a month ago, the ASX 200 share updated its outlook for the 2023 financial year, which was for the 12 months ending 30 September 2023.

In FY23, it expects to report underlying EBITDA in the range of between $430 million to $440 million. Its leverage ratio is expected to be between 2.1 to 2.4 times. Inventory has reduced during the period, though this was "more than offset by an increase in receivables due to the phasing of sales".

Nufarm CEO Greg Hunt said:

We expect to deliver another good result for FY23, following on from the record earnings result delivered in FY22. Despite a very challenging operating environment, we have seen the benefits of revenue diversification across the group, with some softness in crop protection offset by a very strong performance in seed technologies.

We remain on track for our FY26 revenue aspirations.

Nufarm share price valuation

According to L1, the ASX 200 share is trading at roughly 12 times FY24's estimated earnings and on average is delivering earnings per share (EPS) growth of 15% per annum.

In other words, the EPS growth rate is higher than the company's price/earnings (P/E) ratio. When the price-to-earnings-growth (PEG) ratio is less than one, that's seen as an attractive opportunity.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Record Highs

These 2 leading ASX 200 stocks are smashing all-time record highs today

Records are tumbling on the ASX 200 today as two leading stocks charge higher into uncharted territory.

Read more »

Two happy pharmacists standing together in a pharmacy.
Healthcare Shares

ASX 300 healthcare stock Sigma halted amid rumours of blockbuster Chemist Warehouse deal

Is Chemist Warehouse finally joining the ASX?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Chalice Mining, Core Lithium, Perpetual, and Polynovo shares are racing higher

These ASX shares are having a very strong session on Wednesday. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Evolution, Galan Lithium, Life360, and Resolute shares are dropping today

These ASX shares are missing out on the good times today.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Share Market News

Meet the ASX All Ords shares that management is buying up

These shares have all seen significant insider buying over the past week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.

My predictions for the ASX 200 in 2024

2024 could be another volatile year.

Read more »

a man in a suit holds up a hand and a stop sign at a roadblock positioned over a bitumen road .
Capital Raising

Why are Boss Energy shares in a trading halt?

This uranium share is raising funds. But why?

Read more »